| HOME | HELP | E-MAIL ALERTS | SEARCH |
|
PEDIATRICS Vol. 118 No. 3 September 2006, pp. e934-e963 (doi:10.1542/peds.2006-1783)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
TECHNICAL REPORT |
ABSTRACT
Newborn screening fact sheets were last revised in 1996 by the American Academy of Pediatrics Committee on Genetics. This revision was prompted by advances in the field since 1996, including technologic innovations, as well as greater appreciation of ethical issues such as those surrounding informed consent. The following disorders are discussed in this revision of the newborn screening fact sheets: biotinidase deficiency, congenital adrenal hyperplasia, congenital hearing loss, congenital hypothyroidism, cystic fibrosis, galactosemia, homocystinuria, maple syrup urine disease, medium-chain acyl-coenzyme A dehydrogenase deficiency, phenylketonuria, sickle cell disease and other hemoglobinopathies, and tyrosinemia. A series of topics related to newborn screening is discussed in a companion publication to this electronic publication of the fact sheets (available at: www.pediatrics.org/cgi/content/full/118/3/1304). These topics are newborn screening as a public health system; factors contributing to the need for review of the newborn screening system; informed consent; tandem mass spectrometry; DNA analysis in newborn screening; status of newborn screening in the United States; and the effect of sample timing, preterm birth, diet, transfusion, and total parenteral nutrition on newborn screening results.
Key Words: newborn screening screening genetic disorder biotinidase deficiency congenital adrenal hyperplasia congenital hearing loss congenital hypothyroidism cystic fibrosis galactosemia hemoglobinopathies homocystinuria maple syrup urine disease medium-chain acyl-CoA dehydrogenase deficiency phenylketonuria sickle cell disease tyrosinemia tandem mass spectrometry
Abbreviations: OMIM, Online Mendelian Inheritance in Man MS/MS, tandem mass spectrometry CoA, coenzyme A BTD, biotinidase gene CAH, congenital adrenal hyperplasia 21-OH, 21-hydroxylase SW, salt wasting SV, simple virilizing AG, ambiguous genitalia ACTH, adrenocorticotropic hormone 17-OHP, 17-OH-progesterone AABR, automated auditory brainstem response OAE, otoacoustic emission CH, congenital hypothyroidism T4, thyroxine HPT, hypothalamic-pituitary-thyroid CF, cystic fibrosis CFTR, cystic fibrosis transmembrane conductance regulator IRT, immunoreactive trypsinogen GALT, galactose 1-phosphate uridyltransferase GALK, galactokinase GALE, galactose-4'-epimerase CBS, cystathionine ß-synthase BIA, bacterial inhibition assay MSUD, maple syrup urine disease BCKD, branched-chain
-keto acid dehydrogenase BCAA, branched-chain amino acid BCKA, branched-chain
-keto acid E3, dihydrolipoyl dehydrogenase E1, thiamine pyrophosphatedependent decarboxylase E2, transacylase MCAD, medium-chain acyl-coenzyme A dehydrogenase FAO, fatty acid oxidation SIDS, sudden infant death syndrome ADHD, attention-deficit/hyperactivity disorder PKU, phenylketonuria PAH, phenylalanine hydroxylase BH4, tetrahydrobiopterin SCD, sickle cell disease HPLC, high-performance liquid chromatography Hb, hemoglobin HbF, fetal hemoglobin HbA, normal adult hemoglobin FA, fetal and adult hemoglobin MCV, mean corpuscular volume FAH, fumarylacetoacetate hydrolase TAT, tyrosine aminotransferase NTBC, 2-(2-nitro-4-trifluoromethylbenzyl)-1,3-cyclohexanedione
Related Article
The following policy statement has been revised:
This article has been cited by other articles:
![]() |
B. A. Tarini The Current Revolution in Newborn Screening: New Technology, Old Controversies Arch Pediatr Adolesc Med, August 1, 2007; 161(8): 767 - 772. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | E-MAIL ALERTS | SEARCH |